REDAPT

Device Smith+Nephew, Inc.
Total Payments
$2.4M
Transactions
1,458
Doctors
548
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $433,059 327 148
2023 $450,902 166 86
2022 $432,363 268 151
2021 $647,234 400 194
2020 $397,934 297 123

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $1.4M 130 59.7%
Unspecified $445,563 67 18.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $240,979 53 10.2%
Travel and Lodging $95,655 281 4.1%
Consulting Fee $70,511 40 3.0%
Food and Beverage $52,624 878 2.2%
Space rental or facility fees (teaching hospital only) $31,701 7 1.3%
Debt forgiveness $14,016 2 0.6%

Payments by Type

General
$1.9M
1,391 transactions
Research
$445,563
67 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Multicenter, Post Market Clinical Follow-up Study of Subjects with the REDAPT Revision Monolithic Sleeveless Stem and/or Acetabular components Previously Implanted Smith+Nephew, Inc. $94,355 0
2-years outcomes of implanted REDAPT Fully Porous Cup and XLPE Liner Smith+Nephew, Inc. $69,928 0
A Retrospective-Prospective Study of REDAPT Revision Femoral System Modular Stem and/or Acetabular components Previously Implanted Smith+Nephew, Inc. $46,665 0
Data Capture relating to the REDAPT Porous Cups with XLPE Liners Smith+Nephew, Inc. $38,520 0
Data Capture relating to the Retro/Prospective Multi-Centre Data Capture on REDAPT Sleeved Stem Smith+Nephew, Inc. $37,975 0
Data Capture relating to the REDAPT Porous Cups with CLPE Liners Smith+Nephew, Inc. $37,331 0
Data Capture relating to the REDAPT Revision Hip System and AFIT Anthology Hip Stem Smith+Nephew, Inc. $25,000 0
Data Capture relating to the REDAPT Sleeved Stems Smith+Nephew, Inc. $22,750 0
Data captured relating to the REDAPT revision Products Smith+Nephew, Inc. $15,525 0
Data Capture relating to the REDAPT Sleeved Monolithic Stem Smith+Nephew, Inc. $7,105 0

Top Doctors Receiving Payments for REDAPT

Doctor Specialty Location Total Records
Unknown San Diego, CA $496,255 79
, M.D Orthopaedic Surgery New York, NY $400,286 57
, MD Adult Reconstructive Orthopaedic Surgery Charlotte, NC $302,185 22
, M.D Orthopaedic Surgery Houston, TX $228,736 20
, M.D Adult Reconstructive Orthopaedic Surgery Chicago, IL $177,805 16
, MD Orthopaedic Surgery Great Neck, NY $148,724 16
, MD Adult Reconstructive Orthopaedic Surgery Nashville, TN $125,030 14
Steven Weeden Fort Worth, TX $55,880 6
, M.D., PH.D Adult Reconstructive Orthopaedic Surgery Durham, NC $37,511 18
, M.D., M.SC General Acute Care Hospital Orange, CA $36,474 37
, MD Orthopaedic Surgery Los Angeles, CA $23,973 12
, MD Adult Reconstructive Orthopaedic Surgery Omaha, NE $19,154 11
, MD Orthopaedic Surgery Wilmington, NC $18,275 3
, MD Student in an Organized Health Care Education/Training Program Philadelphia, PA $17,783 21
, M.D Orthopaedic Surgery Jacksonville, FL $17,178 39
Herrick Siegel Orthopaedic Surgery Birmingham, AL $16,592 11
, D.O Adult Reconstructive Orthopaedic Surgery Kenosha, WI $15,744 16
, M.D Orthopaedic Surgery Louisville, KY $12,072 13
, PA-C Surgical Falmouth, ME $11,885 1
, MD Adult Reconstructive Orthopaedic Surgery Philadelphia, PA $10,888 10
, MD Adult Reconstructive Orthopaedic Surgery Kansas City, MO $7,303 1
, MD Orthopaedic Surgery Orlando, FL $7,017 8
, M.D Orthopaedic Surgery Atlanta, GA $5,695 14
, MD Orthopaedic Surgery Saint Louis, MO $5,250 4
, M.D., PH. D Adult Reconstructive Orthopaedic Surgery Pittsburgh, PA $4,247 9

About REDAPT

REDAPT is a device associated with $2.4M in payments to 548 healthcare providers, recorded across 1,458 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..

Payment data is available from 2020 to 2024. In 2024, $433,059 was paid across 327 transactions to 148 doctors.

The most common payment nature for REDAPT is "Royalty or License" ($1.4M, 59.7% of total).

REDAPT is associated with 10 research studies, including "A Multicenter, Post Market Clinical Follow-up Study of Subjects with the REDAPT Revision Monolithic Sleeveless Stem and/or Acetabular components Previously Implanted" ($94,355).